BERREY M MICHELLE (President, R&D and CMO) reported 1 transaction at INTERCEPT PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/16/2023ACC: 0001104659-23-033307
Officer· President, R&D and CMO
Since Jun 2021
-1.25K
Net shares
Net seller
$19.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.25K
Price / share
$15.79
Trade value
$19.67K
% of position
1.5%
3/14/2023
83.88K→82.63K
Total
Net shares
−1.25K
Net value
-$19.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/14/2023 | F · Tax Withholding | −1.25K | $15.79 | $19.67K | 1.5% | 83.88K | 82.63K |
| Total | −1.25K | -$19.67K | ||||||
Derivative Transactions0
No derivative transactions reported